Nawal Ouzren - Sensorion CEO Director
| ALSEN Stock | EUR 0.62 0.02 3.13% |
Insider
Nawal Ouzren is CEO Director of Sensorion SA
| Age | 44 |
| Phone | 33 4 67 20 77 30 |
| Web | https://www.sensorion.com |
Sensorion Management Efficiency
The company has return on total asset (ROA) of (0.238) % which means that it has lost $0.238 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4994) %, meaning that it generated substantial loss on money invested by shareholders. Sensorion's management efficiency ratios could be used to measure how well Sensorion manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| DVM MBA | Innate Pharma | 58 | |
| Pr Prasad | Nanobiotix SA | 78 | |
| Stefanie Magner | Genfit | 42 | |
| Earl Bergey | Nanobiotix SA | 68 | |
| Emilie Desodt | Genfit | 40 | |
| Jean Fourni | Innate Pharma | N/A | |
| Franois Romagn | Innate Pharma | 59 | |
| Thomas Baetz | Genfit | 49 | |
| Brandon Owens | Nanobiotix SA | N/A | |
| Pascal Prigent | Genfit | 55 | |
| Kathryn McNeil | Nanobiotix SA | 48 | |
| Frederic MBA | Innate Pharma | 48 | |
| JeanChristophe Marcoux | Genfit | 46 | |
| Elsa Borghi | Nanobiotix SA | N/A | |
| Mondher MD | Innate Pharma | 65 | |
| Marc Bonneville | Innate Pharma | 63 | |
| Pascal Caisey | Genfit | 55 | |
| Laurent Lannoo | Genfit | 53 | |
| Alain Dostie | Nanobiotix SA | N/A | |
| Pr Staels | Genfit | 60 | |
| Odile Belzunce | Innate Pharma | 43 | |
Management Performance
| Return On Equity | -0.5 | |||
| Return On Asset | -0.24 |
Sensorion SA Leadership Team
Elected by the shareholders, the Sensorion's board of directors comprises two types of representatives: Sensorion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sensorion. The board's role is to monitor Sensorion's management team and ensure that shareholders' interests are well served. Sensorion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sensorion's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nawal Ouzren, CEO Director | ||
| Geraldine MD, Chief Officer | ||
| Christine Bec, Head Therapy | ||
| Stephanie Filipe, Head Office | ||
| Catherine Leveau, Head Communication |
Sensorion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sensorion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (4.64) % | |||
| Current Valuation | (3.6 M) | |||
| Shares Outstanding | 79.94 M | |||
| Shares Owned By Insiders | 49.32 % | |||
| Shares Owned By Institutions | 27.00 % | |||
| Price To Earning | (4.37) X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 6.58 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sensorion Stock Analysis
When running Sensorion's price analysis, check to measure Sensorion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensorion is operating at the current time. Most of Sensorion's value examination focuses on studying past and present price action to predict the probability of Sensorion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensorion's price. Additionally, you may evaluate how the addition of Sensorion to your portfolios can decrease your overall portfolio volatility.